Centessa Pharmaceuticals Plc (CNTA) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Centessa Pharmaceuticals Plc  (NASDAQ: CNTA)


Centessa Pharmaceuticals Plc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Centessa Pharmaceuticals Plc's ROI in the first quarter of 2026?
Centessa Pharmaceuticals Plc recorded a cumulative net loss of $-251 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -47.04%.

Within the Healthcare sector 287 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 2172, from total ROI ranking in the fourth quarter of 2025 at 3201.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 9.16 % 16.6 % 22.92 % 56.62 % 49.57 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 605 645 419 462 504
Return On Investment (TTM) -47.04 % -38.93 % -51.21 % -44.92 % -45.86 %
CNTA's Overall Ranking # 2172 # 3201 # 1221 # 3002 # 3522
Seq. Investment Change TTM 5 % 7.07 % -7.59 % 5.07 % 12.16 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -251 -198 -243 -230 -224

CNTA Company Profile >> Back to CNTA Roi Comparisons >> See Annual CNTA Return On Investment



Return On Investment CNTA's Ranking
Within: No.
Industry # 110
Sector # 288
Overall # 2172

Return On Investment Statistics
High Average Low
-9.23 %
-39.01 %
-53.13 %
(Mar 31 2022)   (Dec 31 2024)







Financial Statements
Centessa Pharmaceuticals Plc's I. Quarter Investments $ 605 Millions CNTA's Balance sheet
Centessa Pharmaceuticals Plc's I. Quarter Income $ -79 Millions Quarterly CNTA's Income Statement
CNTA's Income by Division See CNTA's Income by Division


CNTA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 637 511 312 406 605
Y / Y Investment Growth 24.77 % 63.64 % -23.15 % -32.9 % -
Net Income in Millions -198 -236 -151 -216 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -31.01 % -46.18 % -48.43 % -53.26 % -1.76 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNTA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNTA's Competitors
Subscribers only: Roi for Centessa Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Investment for CNTA's Customers

Other Ratios
CNTA's Roa CNTA's Inventory Turnover Ratio CNTA's Growth Rates CNTA's Dividend Statistics
CNTA's Profitability Ratios CNTA's Asset Turnover Ratio CNTA's Dividend Growth
CNTA's Roe CNTA's Valuation Ratios CNTA's Financial Strength Ratios CNTA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:40:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.